Microbix Biosystems Inc.


Date:

(MENAFN- Baystreet) 09:52 AM EST - Microbix Biosystems Inc.: Announces that it has commercialized custom biological materials for incorporation into the lab-based assays or point-of-care test-cartridges of in-vitro diagnostics manufacturers. Initial sales have been made to two DxMs, each of which is incorporating a Microbix biologic material into a new assay or assays. Microbix Biosystems Inc. shares T are trading unchanged at $0.28.

MENAFN19112026000212011056ID1111990790


Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search